122 related articles for article (PubMed ID: 17805043)
1. Secondary acute myeloid leukemia after etoposide therapy for retinoblastoma.
Weintraub M; Revel-Vilk S; Charit M; Aker M; Pe'er J
J Pediatr Hematol Oncol; 2007 Sep; 29(9):646-8. PubMed ID: 17805043
[TBL] [Abstract][Full Text] [Related]
2. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?
Gombos DS; Hungerford J; Abramson DH; Kingston J; Chantada G; Dunkel IJ; Antoneli CB; Greenwald M; Haik BG; Leal CA; Medina-Sanson A; Schefler AC; Veerakul G; Wieland R; Bornfeld N; Wilson MW; Yu CB
Ophthalmology; 2007 Jul; 114(7):1378-83. PubMed ID: 17613328
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma.
Nishimura S; Sato T; Ueda H; Ueda K
J Clin Oncol; 2001 Nov; 19(21):4182-3. PubMed ID: 11689590
[No Abstract] [Full Text] [Related]
4. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
RamaChandran S; Ariffin H
Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
[TBL] [Abstract][Full Text] [Related]
5. Letter to the editor: acute myeloid leukemia in a patient surviving retinoblastoma.
Gallegos-Castorena S; Medina-Sansón A; González-Montalvo P; Martínez-Avalos A; Zafra de la Rosa GZ
Med Pediatr Oncol; 2002 Jun; 38(6):450. PubMed ID: 11984811
[No Abstract] [Full Text] [Related]
6. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
8. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N
Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
[TBL] [Abstract][Full Text] [Related]
9. Lack of activity of oral etoposide for relapsed intraocular retinoblastoma.
Dunkel IJ; Chantada GL; Fandiño AC; Abramson DH
Ophthalmic Genet; 2004 Mar; 25(1):25-9. PubMed ID: 15255111
[TBL] [Abstract][Full Text] [Related]
10. Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide.
Houck W; Abonour R; Vance G; Einhorn LH
J Clin Oncol; 2004 Jun; 22(11):2155-8. PubMed ID: 15169802
[TBL] [Abstract][Full Text] [Related]
11. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Kitazawa J; Ito E; Arai K; Yokoyama M; Fukayama M; Imashuku S
Med Pediatr Oncol; 2001 Aug; 37(2):153-4. PubMed ID: 11496359
[No Abstract] [Full Text] [Related]
12. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
Dunkel IJ; Jubran RF; Gururangan S; Chantada GL; Finlay JL; Goldman S; Khakoo Y; O'Brien JM; Orjuela M; Rodriguez-Galindo C; Souweidane MM; Abramson DH
Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
[TBL] [Abstract][Full Text] [Related]
13. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
Lambert MP; Shields C; Meadows AT
Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
[TBL] [Abstract][Full Text] [Related]
14. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
15. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
Kollmannsberger C; Beyer J; Droz JP; Harstrick A; Hartmann JT; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll HJ; Kanz L; Bokemeyer C
J Clin Oncol; 1998 Oct; 16(10):3386-91. PubMed ID: 9779717
[TBL] [Abstract][Full Text] [Related]
16. [Three cases of secondary acute myeloid leukemia after long-term treatment with oral etoposide].
Kikuta T; Shimazaki C; Hirai H; Sumikuma T; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Fujita N; Hatta T; Nakagawa M
Rinsho Ketsueki; 1996 Nov; 37(11):1276-82. PubMed ID: 8960661
[TBL] [Abstract][Full Text] [Related]
17. [New strategies in the management of retinoblastoma].
Balmer A; Munier F; Zografos L
J Fr Ophtalmol; 2002 Feb; 25(2):187-93. PubMed ID: 11941242
[TBL] [Abstract][Full Text] [Related]
18. Sudden dispersion of retinoblastoma shortly after initial chemotherapy treatment.
Parness-Yossifon R; Bryar PJ; Weinstein JL; Srikumaran D; Mets MB
Am J Ophthalmol; 2009 May; 147(5):903-6. PubMed ID: 19232557
[TBL] [Abstract][Full Text] [Related]
19. Treatment of overt extraocular retinoblastoma.
Chantada G; Fandiño A; Casak S; Manzitti J; Raslawski E; Schvartzman E
Med Pediatr Oncol; 2003 Mar; 40(3):158-61. PubMed ID: 12518344
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Pui CH; Ribeiro RC; Hancock ML; Rivera GK; Evans WE; Raimondi SC; Head DR; Behm FG; Mahmoud MH; Sandlund JT
N Engl J Med; 1991 Dec; 325(24):1682-7. PubMed ID: 1944468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
